High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era

Carmen Hidalgo-Tenorio1, Samantha E. de Jesus1, Javier Esquivias2, Juan Pasquau1
1Servicio de Enfermedades Infecciosas, Hospital Universitario Virgen de las Nieves, Granada, Spain
2Servicio de Anatomía Patológica, Hospital Universitario Virgen de las Nieves, Granada, Spain

Tài liệu tham khảo

Silverberg, 2012, Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America, Clin Inf Dis, 54, 1026, 10.1093/cid/cir1012

Jemal, 2013, Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels, J Natl Cancer Inst, 105, 175, 10.1093/jnci/djs491

Firnhaber, 2012, Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa, J Int AIDS Soc, 15, 17382, 10.7448/IAS.15.2.17382

Piketty, 2008, Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy, AIDS, 22, 1203, 10.1097/QAD.0b013e3283023f78

D'Souza, 2008, Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study, Acquir Immune Defic Syndr, 48, 491, 10.1097/QAI.0b013e31817aebfe

Diamond, 2005, Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy, Sex Transm Dis, 32, 314, 10.1097/01.olq.0000162366.60245.02

Silverberg, 2012, Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America, Clin Infect Dis, 54, 1026, 10.1093/cid/cir1012

Franceschi, 2010, Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study, Br J Cancer, 103, 416, 10.1038/sj.bjc.6605756

Van der Snoek, 2012, Use of highly active antiretroviral therapy is associated with lower prevalence of anal intraepithelial neoplastic lesions and lower prevalence of human papillomavirus in HIV-infected men who have sex with men, Sex Transm Dis, 39, 495, 10.1097/OLQ.0b013e31825aa764

Hidalgo-Tenorio, 2014, Antiretroviral therapy as a factor protective against anal dysplasia in HIV-infected males who have sex with males, PLOS ONE, 27, e92376, 10.1371/journal.pone.0092376

Panel de expertos del Grupo de Estudio de Sida (GESIDA). Documento de consenso sobre diagnóstico y tratamiento de las infecciones de transmisión sexual en adultos, niños y adolescentes (actualización 16 Mar 2017). Available from: http://www.gesida-seimc.org.

European AIDS Clinical Society. Guidelines. Noviembre 2014: 28 (version 7.1). Available from: http://www.europeanaidsclinicalsociety.org.

Hidalgo-Tenorio, 2015, The role of polymerase chain reaction of high-risk human papilloma virus in the screening of high-grade squamous intraepithelial lesions in the anal mucosa of human immunodeficiency virus-positive males having sex with males, PLOS ONE, 10, e0123590, 10.1371/journal.pone.0123590

Salit, 2011, The role of cytology (Pap test) and human papillomavirus testing in anal cancer screening, AIDS, 24, 1307, 10.1097/QAD.0b013e328339e592

Padilla-España, 2014, Usefulness of human papillomavirus testing in anal intraepithelial neoplasia screening in a risk behaviour population, Enferm Infecc Microbiol Clin, 32, 560, 10.1016/j.eimc.2014.03.008

Muñoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med, 348, 518, 10.1056/NEJMoa021641

Solomon, 2002, The 2001 Bethesda system: terminology for reporting results of cervical cytology, JAMA, 287, 2114, 10.1001/jama.287.16.2114

Darragh, 2012, The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology, J Low Genit Tract Dis, 16, 205, 10.1097/LGT.0b013e31825c31dd

Hessol, 2009, Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women, AIDS, 23, 59, 10.1097/QAD.0b013e32831cc101

Gaisa, 2017, High rates of anal high-grade squamous intraepithelial lesions in HIV-infected women who do not meet screening guidelines, Clin Infect Dis, 64, 289, 10.1093/cid/ciw729

Clifford, 2016, Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: a nested case-control study in the Swiss HIV cohort study, Int J Cancer, 138, 1732, 10.1002/ijc.29913

Kost, 2017, Prevalence of human papillomavirus infection of the anal canal in women: a prospective analysis of high-risk populations, Oncol Lett, 13, 2495, 10.3892/ol.2017.5714

Blaser, 2017, Impact of screening and ART on anal cancer incidence in HIV-positive men who have sex with men: mathematical modeling study, AIDS, 10.1097/QAD.0000000000001546

Heard, 2016, Prevalence of and risk factors for anal oncogenic human papillomavirus infection among HIV-infected women in France in the combination antiretroviral therapy era, J Infect Dis, 213, 1455, 10.1093/infdis/jiv751

Kojic, 2011, Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study), Sex Transm Dis, 38, 253, 10.1097/OLQ.0b013e3181f70253

Kang, 2012, Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy, HIV Med, 13, 372, 10.1111/j.1468-1293.2011.00979.x

Hidalgo Tenorio, 2017, Risk factors for infection by oncogenic human papillomaviruses in HIV-positive MSM patients in the ART era (2010–2016), Medicine (Baltimore), 96, e8109, 10.1097/MD.0000000000008109

Feng, 2017, Role of active and passive smoking in high-risk human papillomavirus infection and cervical intraepithelial neoplasia grade 2 or worse, J Gynecol Oncol, 28, E47, 10.3802/jgo.2017.28.e47

Faber, 2017, Risk factors for HIV positivity among more than 3,400 Tanzanian women, Wom Health, 57, 650, 10.1080/03630242.2016.1202882